Advertisement

Topics

Bavarian Nordic Reveals Positive Phase 2 Data for Universal RSV Vaccine

15:00 EDT 30 Jun 2017 | Drug Discovery Development

The randomized, placebo-controlled study enrolled 421 subjects aged 55 and older, at 12 centers across the United States.
Contributed Author: 
Bavarian Nordic
Topics: 

Original Article: Bavarian Nordic Reveals Positive Phase 2 Data for Universal RSV Vaccine

NEXT ARTICLE

More From BioPortfolio on "Bavarian Nordic Reveals Positive Phase 2 Data for Universal RSV Vaccine"

Advertisement
Quick Search
Advertisement
Advertisement